The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products
Active Pharmaceutical Ingredients
AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.
SK Holdings, the parent company of South Korea’s third-largest conglomerate SK Group, announced that it has acquired a 100 percent stake in AMPAC Fine Chemicals, a US-based contract manufacturer of APIs.
The European Medicines Agency (EMA) is reviewing medicines containing the active substance valsartan that is supplied by Zhejiang Huahai Pharmaceuticals, a Chinese pharma company.
Fermion Oy, a privately held Finnish manufacturer of active pharmaceutical ingredients (APIs), has reached a significant milestone in its investment project by entering the commissioning phase of its new plant in Hanko (Finland).
Belarus developed a technology for obtaining a pharmaceutical substance that can be used for manufacturing iodine-based medicines, announced Maria Sekach, Commercial Director of Belaseptika CJSC.
Moscow Endocrine Plant will acquire all sites of the former enterprise for destruction of chemical weapons in the Bryansk region in Q1 2019 aiming at establishing an affiliate for manufacturing active pharmaceutical substances.